Theriva Biologics, Inc. Increase (Decrease) in Other Current Assets
Theriva Biologics, Inc. (TOVX) reported Increase (Decrease) in Other Current Assets of $135.00 thousand for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2012-11-14
- Theriva Biologics, Inc. increase (decrease) in other current assets for the quarter ending 2012-09-30 was $57.00K, a 18.75% increase year-over-year.
- Theriva Biologics, Inc. increase (decrease) in other current assets for the quarter ending 2012-06-30 was $11.00K.
- Theriva Biologics, Inc. increase (decrease) in other current assets for the quarter ending 2012-03-31 was $67.00K.
- Theriva Biologics, Inc. increase (decrease) in other current assets for the quarter ending 2011-12-31 was -$107.00K, a 131.92% decline year-over-year.
- Theriva Biologics, Inc. increase (decrease) in other current assets for fiscal 2011 was -$327.00K, a 197.61% decline from fiscal 2010.
- Theriva Biologics, Inc. increase (decrease) in other current assets for fiscal 2010 was $335.00K.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 6 month as first filed | Increase (Decrease) in Other Current Assets 9 month | Increase (Decrease) in Other Current Assets 9 month as first filed | Increase (Decrease) in Other Current Assets 12 month |
|---|---|---|---|---|---|---|
| 2012-09-30 | $57.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | $68.00K derived: sum of 2 quarters · filed 2012-11-14 | $135.00K 10-Q · filed 2012-11-14 | $28.00K derived: sum of 4 quarters · filed 2012-11-14 | ||
| 2012-06-30 | $11.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-11 | $78.00K 10-Q/A · filed 2012-09-11 | -$29.00K derived: sum of 3 quarters · filed 2012-09-11 | $19.00K derived: sum of 4 quarters · filed 2012-11-14 | ||
| 2012-03-31 | $67.00K 10-Q · filed 2012-05-15 | -$40.00K derived: sum of 2 quarters · filed 2012-05-15 | $8.00K derived: sum of 3 quarters · filed 2012-11-14 | $8.00K derived: sum of 4 quarters · filed 2012-11-14 | ||
| 2011-12-31 | -$107.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-05-11 | -$59.00K derived: sum of 2 quarters · filed 2012-11-14 | -$59.00K derived: sum of 3 quarters · filed 2012-11-14 | -$327.00K 10-K/A · filed 2012-05-11 | ||
| 2011-09-30 | $48.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | $48.00K derived: sum of 2 quarters · filed 2012-11-14 | -$220.00K 10-Q · filed 2012-11-14 | -$219.66K 10-Q · filed 2011-11-14 | $115.16K derived: sum of 4 quarters · filed 2012-11-14 | |
| 2011-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-11 | -$268.00K 10-Q/A · filed 2012-09-11 | -$267.87K 10-Q · filed 2011-08-15 | $67.16K derived: sum of 3 quarters · filed 2012-09-11 | $67.79K derived: sum of 4 quarters · filed 2012-09-11 | |
| 2011-03-31 | -$268.00K 10-Q · filed 2012-05-15 | $67.16K derived: sum of 2 quarters · filed 2012-05-15 | $67.79K derived: sum of 3 quarters · filed 2012-05-15 | |||
| 2010-12-31 | $335.16K derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-05-11 | $335.79K derived: sum of 2 quarters · filed 2012-05-11 | $335.00K 10-K/A · filed 2012-05-11 | |||
| 2010-09-30 | $628.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | -$163.00 10-Q · filed 2011-11-14 | ||||
| 2010-06-30 | -$791.00 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |